Continue to Site

W.L. Gore officials think they can spur insulin delivery system innovation

December 6, 2019 By Chris Newmarker

W.L. Gore announced this week that it is investing in PhysioLogic Devices, a startup developing an implantable intraperitoneal insulin delivery system.

The size of the investment was not disclosed. But it was part of Gore’s Micro-Equity Investment (MEI) program, which provides investments of up to $500,000.

W.L. Gore officials think the company’s more than 60 years in material science competence will help them solve a major technological challenge that implantable insulin delivery systems face: intraperitoneal catheter obstruction.

Get the full story on our sister site Drug Delivery Business News.

About Chris Newmarker

Chris Newmarker is the executive editor of WTWH Media life science's news websites and publications including MassDevice, Medical Design & Outsourcing and more. A professional journalist of 18 years, he is a veteran of UBM (now Informa) and The Associated Press whose career has taken him from Ohio to Virginia, New Jersey and, most recently, Minnesota. He’s covered a wide variety of subjects, but his focus over the past decade has been business and technology. He holds bachelor’s degrees in journalism and political science from Ohio State University. Connect with him on LinkedIn or email at cnewmarker@wtwhmedia.com.